CSS
BLTE

Cubist Systematic Strategies’s Belite Bio BLTE Stock Holding History

Cubist Systematic Strategies’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$344K Buy
4,650
+1,776
+62% +$117K ﹤0.01% 2446
2025
Q2 		$166K Buy
+2,874
New +$175K ﹤0.01% 2640
2024
Q4 		– Sell
-2,019
Closed -$94.7K – 2993
2024
Q3 		$94.7K Buy
+2,019
New +$97.9K ﹤0.01% 2699
2024
Q2 		– Sell
-4,788
Closed -$184K – 3024
2024
Q1 		$184K Sell
4,788
-12,094
-72% -$541K ﹤0.01% 3112
2023
Q4 		$772K Buy
+16,882
New +$649K 0.01% 2253

Other funds holding BLTE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cubist Systematic Strategies's BLTE Position: Q3 2025 in Review

Cubist Systematic Strategies increased its Belite Bio (BLTE) stake by 62% in Q3 2025, buying an estimated $117K and bringing the position to 4,650 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #2446.

Cubist Systematic Strategies first reported a position in BLTE in Q4 2023 and has held it in 5 quarters since. The position peaked at $772K in Q4 2023. 34 funds tracked by Wall St. Rank hold BLTE as of Q3 2025.

  • Cubist Systematic Strategies held 4,650 shares of Belite Bio worth $344K as of Q3 2025.
  • Cubist Systematic Strategies bought 1,776 Belite Bio shares in Q3 2025, an estimated $117K.
  • Belite Bio made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2446 holding.
  • Cubist Systematic Strategies first reported a position in Belite Bio in Q4 2023 and has held it in 5 quarters since.
  • Cubist Systematic Strategies's Belite Bio position peaked at $772K in Q4 2023.
  • 34 funds tracked by Wall St. Rank held Belite Bio as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.